Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Holding(s) in Company

2nd Jun 2006 16:10

Finsbury Emerging Biotechnology Tst02 June 2006 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company Finsbury Emerging Biotechnology Trust PLC 2. Name of shareholder having a major interest Prudential plc and subsidiaries 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 As in 2 above 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them PRUCLT HSBC GIS NOM(UK) PAC AC 5. Number of shares / amount of stock acquired Not disclosed 6. Percentage of issued class * Not disclosed 7. Number of shares / amount of stock disposed Not disclosed 8. Percentage of issued class Not disclosed 9. Class of security Ordinary shares of 25p each 10. Date of transaction Not disclosed 11. Date company informed 2 June 2006 12. Total holding following this notification 4,270,732 13. Total percentage holding of issued class following this notification* 6.47% 14. Any additional information * Based on the issued share capital of 65,912,263 Ordinary shares, following the announcement, on 24 May 2006, of theissue price and basis of allocation of new Ordinary shares concerning a Placing and Offer for Subscription. 15. Name of contact and telephone number for queries Melanie Bell - 020 7426 6224 16. Name and signature of authorised company official responsible for makingthis notification Melanie Bell For and on behalf of Close Finsbury Asset Management Limited Date of notification 2 June 2006 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept any liability for error or omission.The FSA is not liable for any damages (including, without limitation, damagesfor loss of business or loss of profits) arising in contract, tort or otherwisefrom the use of or inability to use this document, or any material contained init, or from any action or decision taken as a result of using this document orany such material. This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

Biotech GwthPrudential
FTSE 100 Latest
Value8,992.12
Change19.48